Baruch Bulvik
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hematology top 10%
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
Papers in
- Oncology 6
- Chemokine receptors and signaling 3
- Co-authors
- Eithan Galun (10 shared papers)Nir Rozenblum (5 shared papers)S. Nahum Goldberg (4 shared papers)Mordechai Chevion (6 shared papers)Evelyne Zeira (4 shared papers)Svetlana Gourevitch (4 shared papers)Hagit Yotvat (3 shared papers)Eduard Berenshtein (5 shared papers)
- Journals
- Radiology (4 papers)PLoS ONE (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- IsraelUnited StatesIsle of Man
In The Last Decade
Baruch Bulvik
17 papers receiving 658 citations
Peers
Comparison fields: 5 of 71
- Hepatology 118
- Hematology 125
- Biotechnology 78
- Immunology 126
- Oncology 141
Countries citing papers authored by Baruch Bulvik
This map shows the geographic impact of Baruch Bulvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baruch Bulvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baruch Bulvik more than expected).
Fields of papers citing papers by Baruch Bulvik
This network shows the impact of papers produced by Baruch Bulvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baruch Bulvik. The network helps show where Baruch Bulvik may publish in the future.
Co-authors
The 25 scholars most cited alongside Baruch Bulvik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 98 | |
| 2 | 2015 | 97 | |
| 3 | 2017 | 89 | |
| 4 | 2015 | 75 | |
| 5 | 2011 | 61 | |
| 6 | 2017 | 50 | |
| 7 | 2008 | 45 | |
| 8 | 2017 | 41 | |
| 9 | 2012 | 28 | |
| 10 | 2008 | 23 | |
| 11 | 2015 | 21 | |
| 12 | 2011 | 17 | |
| 13 | 2013 | 12 | |
| 14 | 2017 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2017 | 1 | |
| 17 | 2015 | 1 |
About Baruch Bulvik
Baruch Bulvik is a scholar working on Oncology, Molecular Biology, Immunology, Nutrition and Dietetics and Hepatology, having authored 17 papers that have together received 663 indexed citations. Recurring topics across this work include Trace Elements in Health (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Immunotherapy and Immune Responses (3 papers), Chemokine receptors and signaling (3 papers), MicroRNA in disease regulation (3 papers), Immune cells in cancer (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Hepatology (118 citations), Hematology (125 citations), Biotechnology (78 citations), Immunology (126 citations) and Oncology (141 citations). Baruch Bulvik has collaborated with scholars based in Israel, United States and Isle of Man. Frequent co-authors include Eithan Galun, Nir Rozenblum, S. Nahum Goldberg, Mordechai Chevion, Evelyne Zeira, Svetlana Gourevitch, Hagit Yotvat, Eduard Berenshtein, Muneeb Ahmed and Katia Beider. Their work appears in journals such as Radiology, PLoS ONE, Journal of Clinical Oncology, Clinical Cancer Research and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.